Janney Montgomery Scott LLC Acquires Shares of 4,067 Bath & Body Works, Inc. (NYSE:BBWI)

Janney Montgomery Scott LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The company bought 4,067 shares of the company’s stock, valued at approximately $203,000.

A number of other hedge funds also made changes to their positions in the stock. Federated Hermes Inc. increased its position in shares of Bath & Body Works by 17.1% in the fourth quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after purchasing an additional 235 shares in the last quarter. Comerica Bank increased its position in shares of Bath & Body Works by 0.9% in the fourth quarter. Comerica Bank now owns 33,091 shares of the company’s stock worth $1,428,000 after purchasing an additional 280 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Bath & Body Works by 72.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after purchasing an additional 337 shares during the period. CWM LLC increased its shares in Bath & Body Works by 7.3% in the fourth quarter. CWM LLC now owns 5,167 shares of the company’s stock worth $223,000 after purchasing an additional 353 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its shares in Bath & Body Works by 1.3% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 31,475 shares of the company’s stock worth $1,349,000 after purchasing an additional 414 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works shares rise 3.1%

Shares of NYSE BBWI opened at $34.17 on Friday. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $52.99. The company’s 50-day simple moving average is $42.08 and its 200-day simple moving average is $44.30. The stock has a market cap of $7.63 billion, a price/earnings ratio of 8.81, a price/earnings/growth ratio of 1.13 and a beta of 1.85.

Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Tuesday, June 04. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.05. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. The company had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.37 billion. In the same period last year, the company earned $0.33 EPS. The company’s revenue was down 0.9% year-over-year. On average, sell-side analysts expect Bath & Body Works, Inc. to post 3.29 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 21st. Investors of record on Friday, June 7th were paid a dividend of $0.20 per share. This represents an annualized dividend of $0.80 and a dividend yield of 2.34%. The ex-dividend date was Friday, June 7th. Bath & Body Works’ dividend payout ratio currently stands at 20.62%.

Changes in analyst ratings

A number of equities analysts have commented on the stock. Telsey Advisory Group affirmed an “outperform” rating and gave a $53.00 price target on shares of Bath & Body Works in a report on Tuesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Bath & Body Works from $53.00 to $57.00 in a report on Monday, June 3rd. Wells Fargo & Company lowered their price target on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the company in a report on Wednesday. JPMorgan Chase & Co. raised shares of Bath & Body Works from an “underweight” rating to a “neutral” rating and raised their price target on the stock from $40.00 to $53.00 in a report on Friday, May 17th. Finally, BMO Capital Markets raised their price objective on shares of Bath & Body Works from $50.00 to $55.00 and gave the stock an “outperform” rating in a report on Wednesday, June 5th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Bath & Body Works has a consensus rating of “Hold” and an average price objective of $47.60.

View our latest research report on BBWI

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc. operates a specialty retail store featuring home fragrance, body care, and soaps and sanitizers. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by affiliates under franchise, licensing, and wholesale arrangements.

Also see

Get daily news and reviews for Bath & Body Works – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings on Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.